This is in stark contrast to cutaneous melanoma, where B-Raf proto-oncogene, serine/threonine kinase (BRAF) and neuroblastoma RAS viral oncogene homolog (NRAS) mutations predominate [4,5]. The gene discussed is BRAF; the disease is cutaneous melanoma.